PMC:7307149 / 6960-7255 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T48","span":{"begin":140,"end":143},"obj":"Body_part"}],"attributes":[{"id":"A48","pred":"fma_id","subj":"T48","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"We performed the same analyses for the closely related SARS-CoV proteome (see Fig. S1 in the supplemental material) and similarly note that HLA-B*46:01 was predicted to present the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T50","span":{"begin":55,"end":63},"obj":"Disease"},{"id":"T51","span":{"begin":188,"end":196},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"mondo_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A51","pred":"mondo_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"We performed the same analyses for the closely related SARS-CoV proteome (see Fig. S1 in the supplemental material) and similarly note that HLA-B*46:01 was predicted to present the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T71","span":{"begin":83,"end":85},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T72","span":{"begin":144,"end":145},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T73","span":{"begin":197,"end":205},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"We performed the same analyses for the closely related SARS-CoV proteome (see Fig. S1 in the supplemental material) and similarly note that HLA-B*46:01 was predicted to present the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20","span":{"begin":197,"end":205},"obj":"Chemical"}],"attributes":[{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"We performed the same analyses for the closely related SARS-CoV proteome (see Fig. S1 in the supplemental material) and similarly note that HLA-B*46:01 was predicted to present the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"157","span":{"begin":140,"end":145},"obj":"Gene"},{"id":"161","span":{"begin":55,"end":63},"obj":"Species"},{"id":"162","span":{"begin":188,"end":196},"obj":"Species"}],"attributes":[{"id":"A157","pred":"tao:has_database_id","subj":"157","obj":"Gene:3106"},{"id":"A161","pred":"tao:has_database_id","subj":"161","obj":"Tax:694009"},{"id":"A162","pred":"tao:has_database_id","subj":"162","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We performed the same analyses for the closely related SARS-CoV proteome (see Fig. S1 in the supplemental material) and similarly note that HLA-B*46:01 was predicted to present the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T48","span":{"begin":0,"end":295},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We performed the same analyses for the closely related SARS-CoV proteome (see Fig. S1 in the supplemental material) and similarly note that HLA-B*46:01 was predicted to present the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49)."}

{"project":"2_test","denotations":[{"id":"32303592-12969506-65501635","span":{"begin":291,"end":293},"obj":"12969506"}],"text":"We performed the same analyses for the closely related SARS-CoV proteome (see Fig. S1 in the supplemental material) and similarly note that HLA-B*46:01 was predicted to present the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49)."}